Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Kimberly H, Allison"'
Autor:
William J. Gradishar, Meena S. Moran, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, Bethany Anderson, Harold J. Burstein, Helen Chew, Chau Dang, Anthony D. Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Sara A. Hurvitz, Steven J. Isakoff, Rachel C. Jankowitz, Sara H. Javid, Jairam Krishnamurthy, Marilyn Leitch, Janice Lyons, Joanne Mortimer, Sameer A. Patel, Lori J. Pierce, Laura H. Rosenberger, Hope S. Rugo, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, Erica M. Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica S. Young, Jennifer Burns, Rashmi Kumar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:691-722
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, inva
Autor:
Fabrice Andre, Nofisat Ismaila, Kimberly H. Allison, William E. Barlow, Deborah E. Collyar, Senthil Damodaran, N. Lynn Henry, Komal Jhaveri, Kevin Kalinsky, Nicole M. Kuderer, Anya Litvak, Erica L. Mayer, Lajos Pusztai, Rachel Raab, Antonio C. Wolff, Vered Stearns
Publikováno v:
Journal of Clinical Oncology. 40:1816-1837
PURPOSE To update recommendations on appropriate use of breast cancer biomarker assay results to guide adjuvant endocrine and chemotherapy decisions in early-stage breast cancer. METHODS An updated literature search identified randomized clinical tri
Autor:
Saleh Najjar, Kimberly H. Allison
Publikováno v:
Virchows Archiv. 480:163-176
Autor:
Gregory R. Bean, Ryanne A. Brown, Jeffrey M. Cloutier, Elizabeth M. Hosfield, Joaquin J. Garcia, Gregory W. Charville, Megan L. Troxell, Kimberly H. Allison, Christian A. Kunder
Publikováno v:
Modern Pathology. 34:1865-1875
Nodular fasciitis is a benign, self-limited, pseudosarcomatous neoplasm that can mimic malignancy due to its rapid growth, cellularity, and mitotic activity. Involvement of the breast is rare and diagnosis on biopsy can be challenging. In this larges
Autor:
Dustin E Bosch, Melissa Lerch, Lei Zhao, Pei Wang, Laura C Kennedy, Kimberly H. Allison, Andrew N. Hoofnagle, Regine M. Schoenherr, Amanda G. Paulovich, Chenwei Lin, Mark R. Kilgore, Jacob J. Kennedy, Jeffrey R. Whiteaker, Geoffrey S. Baird, Shrabanti Chowdhury
Publikováno v:
Clin Chem
Background Conventional HER2-targeting therapies improve outcomes for patients with HER2-positive breast cancer (BC), defined as tumors showing HER2 protein overexpression by immunohistochemistry and/or ERBB2 gene amplification determined by in situ
Autor:
Tara M Davidson, Mara H Rendi, Paul D Frederick, Tracy Onega, Kimberly H Allison, Ezgi Mercan, Tad T Brunyé, Linda G Shapiro, Donald L Weaver, Joann G Elmore
Publikováno v:
Journal of Pathology Informatics, Vol 10, Iss 1, Pp 11-11 (2019)
Background: To assess reproducibility and accuracy of overall Nottingham grade and component scores using digital whole slide images (WSIs) compared to glass slides. Methods: Two hundred and eight pathologists were randomized to independently interpr
Externí odkaz:
https://doaj.org/article/93027906ba7342dcbac2b926e5086db3
Autor:
Gregor Krings, Gregory R. Bean, Robert B. West, Elizabeth M. Hosfield, Francisco Beca, Kimberly H. Allison, Yunn-Yi Chen, Richard K. Sibley, Megan L. Troxell, Poonam Vohra
Publikováno v:
Modern Pathology. 33:1518-1526
Angiosarcoma (AS) is the most frequent primary sarcoma of the breast but nevertheless remains uncommon, accounting for
Autor:
Yosr Bouhlal, Soo-Ryum Yang, Anna Vilborg, Francisco M. De La Vega, Calvin J. Kuo, Kimberly H. Allison, Greg Jensen, Morgan Ballard
Publikováno v:
Modern Pathology. 33:1546-1556
In patients with invasive breast cancer, fluorescence in situ hybridization (FISH) testing for HER2 typically demonstrates the clear presence or lack of ERBB2 (HER2) amplification (i.e., groups 1 or 5). However, a small subset of patients can present
Autor:
Mitchell Dowsett, Jane Perlmutter, Antonio C. Wolff, M. Elizabeth H. Hammond, Meredith M. Regan, Giuseppe Viale, Sunil R. Lakhani, W. Fraser Symmans, Lisa M. McShane, Mariana Chavez-MacGregor, Shannon E. McKernin, Kimberly H. Allison, Lisa A. Carey, David L. Rimm, Patrick L. Fitzgibbons, Emina Torlakovic, Leticia Varella, Tracey Weisberg, Daniel F. Hayes, Charles M. Perou
Publikováno v:
Journal of Clinical Oncology. 38:1346-1366
PURPOSETo update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) testing in breast cancer guideline.METHODSA multidisciplinary international Expert Panel
Publikováno v:
Archives of Pathology & Laboratory Medicine. 144:1525-1534
Context.— Accurate HER2 testing in breast cancer is crucial for appropriate precision therapy. HER2 testing is most commonly accomplished by a combination of immunohistochemistry and in situ hybridization techniques, as gene amplification is closel